Results of surgery for a compound adrenal tumor consisting of pheochromocytoma and ganglioneuroblastoma in an adult: 5-year follow-up

Internal Medicine

Volumn 39, Issue 1, 2000, Pages 58-62

  Fujiwara, Takuya ^a   Kawamura, Minoru ^a   Sasou, Shunichi ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant therapy; Long term outcome; Prognosis; Shimada classification

Indexed keywords

ADRENAL TUMOR; ADULT; CASE REPORT; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MULTIPLE CANCER; NEUROBLASTOMA; PATHOLOGY; PHEOCHROMOCYTOMA; REVIEW; SURVIVOR;

ADRENAL GLAND NEOPLASMS; ADULT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GANGLIONEUROBLASTOMA; HUMANS; NEOPLASMS, MULTIPLE PRIMARY; PHEOCHROMOCYTOMA; SURVIVORS;

EID: 0033627766     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.58     Document Type: Article

References (21)

1. Nakagawara A, Ikeda K, Tsuneyoshi M, Daimaru Y, Enjoji M. Malignant pheochromocytoma with ganglioneuroblastomatous elements in a patient with von Recklinghausen's disease. Cancer 55: 2794-2798, 1985.
2. Nigawara K, Suzuki T, Tazawa H, et al. A case of recurrent malignant pheochromocytoma complicated by watery diarrhea, hypokalemia, achlorhydria syndrome. J Clin Endocrinol Metab 65: 1053-1056, 1987.
3. Donadio F, La Ganga V, Vajo M, Campanella G, Coverlizza S. Ganglioneuroblastoma with areas of pheochromocytoma of the adrenal gland. Case report. Minerva Chir 37: 551-558, 1982 (in Italian, Abstract in English).
4. Tischler AS, Dayal Y, Balogh K, Cohen RB, Connolly JL, Tallberg K. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol 18: 909-917, 1987.
5. Kimura N, Miura Y, Miura K, et al. Adrenal and retroperitoneal mixed neuroendocrine-neural tumors. Endocr Pathol 2: 139-147, 1991.
6. Kilton LJ, Aschenbrener C, Burns CP. Ganglioneuroblastoma in adults. Cancer 37: 974-983, 1976.
7. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405-416, 1984.
8. Chatten J, Shimada H, Sather HN, Wong KY, Siegel SE, Hammond GD. Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group. Hum Pathol 19: 1187-1198, 1988.
9. Schlumberger M, Gicquel C, Lumbroso J, et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15: 631-642, 1992.
10. Adam A, Hochholzer L. Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer 47: 373-381, 1981.
11. Hiroshige K, Sonoda S, Fujita M, Takasugi M, Kuroiwa A, Inatomi H. Primary adrenal ganglioneuroblastoma in an adult. Intern Med 34: 1168-1173, 1995.
12. Cameron DG, Warner HA, Szabo AJ. Chronic diarrhea in an adult with hypokalemic nephropathy and osteomalacia due to a functioning ganglioneuroblastoma. Am J Med Sci 253: 417-424, 1967.
13. Roberts NB, Dutton J, White MC, Winstanley J, Sells RA. An adrenaline-secreting ganglioneuroblastoma with elevated urinary HMMA but normal metanephrine excretion. Ann Clin Biochem 29: 678-680, 1992.
14. Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK. Neuroblastoma in adults and adolescents. An indolent course with poor survival. Cancer 79: 2028-2035, 1997.
15. Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29: 1133-1139, 1997.
16. Noshiro T, Shimizu K, Watanabe T, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Hypertens Res 20: 304, 1997 (Abstract).
17. Voorhess ML. Neuroblastoma-pheochromocytoma: products and pathogenesis. Ann NY Acad Sci 230: 187-194, 1974.
18. Kedar A, Glassman M, Voorhess ML, et al. Severe hypertension in a child with ganglioneuroblastoma. Cancer 47: 2077-2080, 1981.
19. Proye C, Fossati P, Fontaine P, et al. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100: 1154-1162, 1986.
20. Tippett PA, West RS, McEwan AJ, Middleton JE, Ackery DM. A comparison of dopamine and homovanillic acid excretion, as prognostic indicators in malignant phaeochromocytoma. Clin Chim Acta 166: 123-133, 1987.
21. Manu P, Runge LA. Biochemical screening for pheochromocytoma. Superiority of urinary metanephrines measurements. Am J Epidemiol 120: 788-790, 1984.